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The induced colorectal carcinogenesis in rodents has a long history and currently uses the
substances  1,2-dimethylhydrazine and azoxymethane.
Objective: The aim of this study was to compare the inductive effect of the substances
azoxymethane and 1,2-dimethylhydrazine in colorectal carcinogenesis.
Method:  30 randomly chosen male Wistar rats were divided into four groups. G1 group was
treated  with 1,2-dimethylhydrazine and C1 was its control group; G2 group was  treated
azoxymethane  and C2 was its control group. The animals were  weekly weighed until
euthanasia,  when their intestines were removed, processed and analyzed by an experienced
pathologist.
Results:  Among the control groups (C1 and C2) no histologic changes were  observed; mod-
erate  dysplasia was detected in G2 group; hyperplasia, mild dysplasia, severe dysplasia and
carcinoma were observed in G1 group. When this study compared the cost of the substances,
1,2-dimethylhydrazine was more than 50 times less expensive than azoxymethane.
Conclusion:  Azoxymethane is able to promote histological changes consistent with colorectal
carcinogenesis. 1,2-Dimethylhydrazine produced neoplasia and dysplasia, and, compared
to  the azoxymethane, was more efﬁcient in the induction of colorectal cancer.© 2014 Sociedade Brasileira de Coloproctologia. Published by Elsevier Editora Ltda. 
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Estudo  comparativo  das  substâncias  1,2-dimetil-hidrazina  e  azoximetano
na  induc¸ão  de  câncer  colorretal  em  ratos
Palavras-chave:
Câncer colorretal
Modelo experimental
Carcinogênese
Azoximetano
1,2-Dimetil-hidrazina
r  e  s  u  m  o
A carcinogênese colorretal induzida em roedores tem longa história e utiliza, atualmente,
as substâncias 1,2 dimetil-hidrazina (DMH) e azoximetano (AOM).
Objetivo:  Comparar o efeito indutivo das substâncias AOM e DMH  para o câncer colorretal
(CCR).
Método: 30 ratos Wistar machos foram randomizados em quatro grupos. O grupo G1 foi
inoculado com DMH, o grupo C1 foi seu controle; G2 recebeu o AOM e C2 foi seu controle.
Os animais foram pesados semanalmente até a eutanásia, quando tiveram seus intestinos
retirados, processados e analisados por um patologista experiente.
Resultados:  Os animais dos grupos de controle apresentaram tecido colorretal normal e os
animais do grupo G2 apresentaram um padrão de displasia moderada. Nas lâminas do grupo
G1, foram encontradas regiões de hiperplasia, displasia leve, displasia grave, e carcinoma.
Comparado o custo das substâncias AOM e DMH, este último teve um prec¸o  mais de 50
vezes menor ao do AOM.
Conclusão:  AOM é capaz de promover alterac¸ões  histológicas compatíveis com a carcinogê-
nese colorretal. DMH produziu neoplasia e displasia grave e, comparada ao AOM, foi mais
eﬁciente na induc¸ão  do câncer colorretal.
©  2014 Sociedade Brasileira de Coloproctologia. Publicado por Elsevier Editora Ltda.
Este é um artigo Open Access sob a licença de CC BY-NC-NDIntroduction
The number of new cases of colon and rectal cancer estimated
for  Brazil in 2012 is 30,140, with 14,180 in men  and 15,960 in
women.1
The etiology of colorectal cancer (CRC) is known to be multi-
factorial,  including family, environmental and dietary agents.
Despite  many  advances in our understanding of the pro-
cesses  of carcinogenesis, to date, therapies including surgery,
radiation  and chemotherapy drugs are still limited to treat
advanced  stages of CRC.2–4 The only satisfactory answer to
the  problem of malignancy is its prevention. This involves an
extensive search for acquiring knowledge of the basic aspects
of  carcinogenesis.5,6
The carcinogenesis and development of CRC are multi-
step  processes, characterized by progressive changes in the
amount  or activity of proteins that regulate the proliferation,
differentiation, and cell survival, and that are mediated by
genetic  mechanisms. An ordered sequence of non-random
events leads to the development of colorectal cancer, with
the  epithelium undergoing an invasive transformation, with
progression  from normal intestinal epithelium to the devel-
opment  of invasive carcinoma.5,7–12
Animal models are good chances to study the biology of dis-
ease  development. In addition, these models allow for testing
hypotheses  relating environmental factors to the etiology and
prevention  of cancer.7
The study of colorectal carcinogenesis in rodents has
a  long history, dating back approximately 80 years. Cur-
rently,  experimental models use colorectal carcinogens
1,2-dimethylhydrazine (DMH) and azoxymethane (AOM).13–16
DMH  falls in the category of an indirect inducer drug. This
drug  has the ability to promote DNA hypermethylation ofcolorectal epithelial cells in the segment. AOM is a derivative
of  dimethylhydrazine. However, unlike DMH, AOM falls under
the  category of a direct inducer, without relying on conversion
in  vivo.17
This study aims to compare the inductive effect of the sub-
stances  AOM and DMH for colorectal carcinoma in an attempt
to  identify a more  efﬁcient animal model for the induction of
CRC  in rats.
Method
Animals
30 Wistar rats from the Central Animal Laboratory, Univer-
sidade  Federal de Alagoas (UFAL), submitted to a light–dark
cycle  of 12 h, and fed with standard diet and water ad libi-
tum,  were used. The study was approved by the Ethics in
Research  Committee (ERC), Universidade Federal de Alagoas,
and  all experimental steps were  performed in accordance
with the principles established by the Colégio Brasileiro de
Experimentac¸ão  Animal (COBEA).
Experimental  groups  and  technique
The animals were randomized into four groups: two groups of
ten  animals (G1 and G2) and two of ﬁve (C1 and C2). G1 was
submitted to induction by DMH, and C1 was  its control group.
G2  received AOM and C2 was  its control group.
DMH was administered dissolved in 0.9% NaCl containing
1.5% EDTA as a vehicle, adjusted to a ﬁnal pH of 6.5 with 1 N
NaOH  solution and applied subcutaneously once a week for
ﬁve  weeks at a dose of 65 mg/kg/week.18
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AOM was  administered dissolved in 0.9% NaCl, resulting in
OM  20 mg/mL  and applied subcutaneously for two weeks at
 dose of 20 mg/kg/wk.3
In C1 and C2, only saline (sodium chloride 0.9%) was  applied
n  a proportional volume and in the same time scheme of G1
nd  G2, respectively.
After  the second inoculation of AOM, we  waited two weeks
or  the action of this substance, and ten weeks for the action
f  DMH, after its ﬁfth inoculation. The animals were prop-
rly  identiﬁed and submitted to the administration of sodium
hiopental  150 mg/kg, intraperitoneally, whose lethal dose
aused  a quick and painless death by central nervous action
ith  cardiopulmonary arrest.3,18
Immediately after euthanasia, the intestine was  removed
n  bloc from the cecum to the anus and opened with scissors in
he antimesenteric border. The gut was  stretched in Styrofoam
lates  for cleaning with 0.9% NaCl.
istopathology
issues were  ﬁxed in 10% buffered formaldehyde for 24 h and
hereafter  dehydrated in increasing concentrations of ethanol.
fter  dehydration, the samples were  embedded in parafﬁn,
nd  from these materials tissue sections were obtained and
ubsequently mounted on glass slides, which were stained
ith  hematoxylin–eosin (HE). The slides were  analyzed by an
xperienced  pathologist.
Histopathological changes were  classiﬁed as mild, moder-
te  and severe dysplasias. Mild dysplasia was  characterized
s  having elongated, crowded and pseudo-stratiﬁed nuclei
ith  preserved polarity and a normal or slightly reduced
umber of goblet cells. Moderate dysplasia was  character-
zed  as having hyperchromatic proprieties and deformity
f  the cell nuclei, increased number of mitoses, thicken-
ng  of the glandular epithelium and an increased number
f  immune (defense) cells in the connective tissue. Severe
ysplasia was  characterized as having broad, round or ovoid
uclei  with prominent nucleoli, and atypical mitotic ﬁgures.
n  severe dysplasia, the nuclear polarity was  partially lost
nd  the number of goblet cells was  signiﬁcantly reduced or
ompletely  disappeared. Colorectal carcinoma is character-
zed  by a complete loss of the morphological characteristics
f  the tissue of origin and by the presence of signet ring
ells.19,20
esults
eight  gain
he animals were  weighed weekly, from the ﬁrst inoculation
ntil  euthanasia. Table 1 shows the weight of each G1 animal
ver  the 15 weeks of the experiment, and Table 2 shows the
eight  of each C1 animal in the same period of time. Fig. 1
ompares  the weight evolution of G1 versus C1 animals in the
eeks  of evaluation. Table 3 shows the weight of each G2 ani-
al  over the four weeks of the experiment, and Table 4 shows
he  weight of C2 animals in the same period of time. Fig. 2
ompares  the weight evolution of G2 versus C2 animals in the
eeks  of evaluation.
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Table 3 – Weight gain, in grams, of each animal of G2
group  during the trial period.
Animals Week 1 Week 2 Week 3 Week 4
1 174.5 128.0 193.6 218.8
2 174.8 145.3 164.3 196.6
3 168.8 168.6 196.2 212.1
4 155.1 164.7 198.8 215.4
5 154.5 158.4 160.5 187.3
6 156.8 135.5 165.5 186.5
7 152.5 146.3 161.6 188.8
8 180.0 183.0 194.4 236.3
9 209.0 216.0 220.2 253.6
10 197.0 157.0 191.6 236.1
Mean 172.3 160.3 184.7 213.2
Table 4 – Weight gain, in grams, of each animal of C2
control  group during the trial period.
Animals Week 1 Week 2 Week 3 Week 4
1 191.0 226.0 245.6 257.6
2 202.0 234.0 254.5 272.3
3 218.0 252.0 290.7 318.7
4 164.5 190.2 217.7 229.9
5 170.7 198.1 211.5 223.6Mean 189.2 220.1 244.0  260.4
Histological  analysis
No macroscopic lesion in colorectal tissue of any animal was
found.
The  animals in the control groups showed normal colorec-
tal  tissue. In the slides studied, the homogeneous pattern of
staining  in the nuclei was  maintained, as well as its basal loca-
tion.  No mitotic tissue changes were observed, as well as in the
size  or shape of the glands, which remained uniform (Fig. 3).
G2  animals showed changes consistent with moderate dys-
plasia  (Fig. 4). In G1 slides, areas of hyperplasia (Fig. 5), mild
dysplasia  (Fig. 6), severe dysplasia (Fig. 7) and carcinoma (Fig. 8)
were observed.
Discussion
In the weight evolution in the control groups (C1 and C2), an
increasing  weight gain occurred.
In G2 group, i.e. those animals that received AOM, there was
a  weight loss in the ﬁrst week and, thereafter, weight gain.
Probably  this was due to the metabolism of this substance,
that  acts directly in carcinogenesis.15
A difference in weight evolution of G1 and C1 was  noted,
compared to G2 and C2. In the group that received DMH  (G1),
although  there has been no weight loss, weight gain was con-
sistently  lower than in the control group. This weight behavior
was  not analyzed in similar studies; however the research con-
ﬁrm different metabolisms between DMH and AOM, which can
generate further research to justify such developments.15,21
Regarding the microscopic morphology, in G2 group
changes in a homogeneous pattern were observed and char-
acterized  as moderate dysplasia. In this group carcinoma
was  not obtained, perhaps due to the short time between
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Fig. 1 – Comparative weight evolution, in grams, between G1 and C1 groups in the ﬁfteen weeks of evaluation.
W
ei
gh
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) G2,1,172.3
C2,1,189.2
G2,2,160.3
C2,2,220.1
Time (weeks)
G2,3,184.7
C2,3,244.0
G2,4,213.2
C2,4,260.4
G2
C2
Fig. 2 – Comparative weight evolution, in grams, between
Fig. 3 – Photomicrograph of colonic tissue stained with HE,
representing  a normal pattern of control groups. G2 and C2 groups in the four weeks of evaluation.
inoculation and euthanasia, since other studies have iden-
tiﬁed  carcinoma when the time elapsed was  superior to
ours.15,19,22,23
The analysis of G1 slides showed histological changes
in  different stages, which conﬁrmed the high carcinogenic
capacity of DMH.7,13,15,18,21,24
It is known that the ﬁnal amount of carcinogen found in
the  tissues is a function of activity of the metabolic path-
ways  leading to its formation, of the activity of detoxiﬁcation
pathways, as well as the half-lives of all biological species
involved.25 Considering that in the methodology of DMH  car-
cinogenesis  15 weeks should elapse for the ﬁnal analysis,
there was  more  time for the evolution of lesions, which con-
ﬁrms  the importance of genetic and environmental factors in
carcinogenesis.12
The mechanism of carcinogenesis induction by inoculation
of  AOM and DMH is so well established in the literature that
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Fig. 4 – Photomicrograph of colonic tissue stained with HE,
showing  a pattern of moderate dysplasia (G2 group).
Fig. 5 – Photomicrograph of colonic tissue stained with HE,
showing  hyperplasia of glandular epithelium (G1 group).
Fig. 6 – Photomicrograph of colonic tissue stained with HE,
with  mild dysplasia (G1 group).
Fig. 7 – Photomicrograph of colonic tissue stained with HE,
exhibiting  severe dysplasia (G1 group).
Fig. 8 – Photomicrograph of colonic tissue stained with HE,
featuring  carcinoma – the arrow signals a signet ring cell
(G1  group).
some authors are using substances to inhibit the carcinogenic
process.5,22,24,26,27 However, the cost of substances – a limiting
factor of the feasibility of an experiment – is not being ana-
lyzed  nor valued.
When  in this study we compared the cost of AOM versus
DMH,  the latter was  more  than 50 times less expensive than
AOM.  Even requiring more  carcinogenesis time with DMH and,
consequently, an higher maintenance cost of animals, the use
of AOM did not pay off.
The  methodology used conﬁrmed that the ﬁve weeks’ time
of  inoculation followed by ten weeks of observation is sufﬁ-
cient  for completion of experimental carcinogenesis by DMH.
Conclusion
DMH caused changes of weight different from those of G2
animals.  Their carcinogenic action was evidenced by patho-
logical  changes, as dysplasias of various degrees were  found,
in  addition to regions of neoplasia. AOM is able to promote his-
tological changes consistent with the orderly events’ sequence
2 0 1 4
t
s
c
D
c
C
T
r
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2j coloproctol (rio j). 
hat leads to the development of colorectal cancer, being con-
idered  a good colorectal carcinogen.
Time is a preponderant factor for evidencing the histologi-
al  changes. Neoplasia and severe dysplasia were produced by
MH which, compared to AOM, was  more  efﬁcient in inducing
olorectal  cancer.
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